ACCEL LAB Ltd. announced that it will receive a series B round of funding on January 25, 2023. The company will issue through a third-party allotment. The company will issue common stock in the transaction.

On the same date, the company has received ¥780,000,000 in its first tranche closing from Kenedix, Inc..